Delivery Order SPE2DB20D2002-SPE2DB24FL81T
Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,654.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024, and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, with an ID of SPE2DB20D2104 and SPE2DB24FT91L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,101.45 firm fixed-price delivery order is for the supply of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there are no set-aside...
- This federal contract award, valued at $11,328.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,968,141 units of the medication LINZESS 145 MCG CAPSULE. The contract has a firm fixed price and an ultimate completion date of April 21, 2025. This award is not associated with a set-aside program and appears to be an open competition contract....
- This federal contract award, valued at $1,721.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the product LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical item. The contract has an Ultimate Completion Date of November 25, 2024 and was awarded on November 22, 2024. It is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite...
- This federal contract award, with an ID of SPE2DB20D2014|SPE2DB25FA78E, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S, with a total ceiling value of $3,417.07. It is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 14, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award, valued at $1,891.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product, with a performance period extending through May 12, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, SPE2DB22D1106|SPE2DB25FEBL0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, and has a ceiling value of $13,535.10. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 5, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $1,727.04, is for the delivery of 4565483128 LINZESS 72 MCG CAPSULE UU 30S pharmaceutical products. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 19, 2024. This award does not have a set-aside designation. Amerisourcebergen Drug Corp, a major...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,742.20 with a firm fixed price. The contract is for LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product, with a period of performance running through March 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $1,337.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, with a completion date of December 2, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...